Search results for "Vaccinations"

Results 51 - 60 of about 279 for "Vaccinations".
Sort by: Relevance | Newest | Oldest

Primary Care Collaborative's Feb. 23 webinar addresses the effort to vaccinate Americans

In this webinar, experts will provide different perspectives on the role of primary care and other sectors as the distribution of the vaccines against COVID-19 ramps up.
23 Feb 2021

Postexposure prophylaxis drug, vaccine complications, and anticoagulation in COVID-19

A monoclonal antibody combination was effective for postexposure prophylaxis and received emergency use authorization. A study investigated postvaccine myocarditis and pericarditis, and effects of full-dose anticoagulation differed by whether patients were critically ill.
10 Aug 2021

COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia

Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
15 Jun 2021

CDC recommendations on COVID-19 vaccine boosters, new data on vaccine effectiveness

Several groups in the U.S. are now eligible to receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine at least six months after completing the initial two-dose series.
28 Sep 2021

New research adds to data on symptoms after COVID-19, vaccines' effects

Several COVID-19 studies looked at persistent symptoms, while new vaccine research found limited antibody responses in some patients and advised on tests for clotting complications. Other studies quantified the target population for tocilizumab treatment and gender differences in infections.
25 May 2021

Many recent studies reporting on COVID-19 vaccines' safety, effectiveness

New studies looked at the safety of the adenovirus COVID-19 vaccines, the effectiveness of almost all the vaccines, and the impacts of COVID-19 infection in pregnancy and on long-term cardiac function. A physician columnist addressed pandemic-related anger.
11 May 2021

Treatment for high-risk COVID-19 patients, vaccine news, research on health messaging

An industry-funded study found benefit with bamlanivimab plus etesevimab for high-risk ambulatory COVID-19 patients, the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine, and two studies looked at COVID-19 messaging for minority populations.
20 Jul 2021

Latest on COVID-19 and bamlanivimab, vaccines, long-term effects

Bamlanivimab reduced viral load in mild to moderate cases when combined with etesevimab, new vaccine recommendations, research, and educational resources were released, and two studies provided longer-term data on patients who had COVID-19.
26 Jan 2021

Studies assess responses, reactions to vaccines; long-term effects of COVID-19 infection

Recent COVID-19 vaccine studies showed good response in pregnant women, as well as possible localized rashes from the Moderna vaccine. Analyses of ICU patients and those treated at a post-COVID-19 clinic highlighted the long-term effects of the virus, and a study found that dialysis patients maintained antibodies six months after COVID-19 infection.
18 May 2021

Little health benefit, higher costs likely with extended age limit for HPV vaccination

A modeling study examined four scenarios for extended vaccination in women and men up to ages 26, 30, 40, and 45 years.
10 Dec 2019

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next